| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Waleed H Hassanein is President & CEO at TMDX. Waleed H Hassanein's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $11.5M at current prices.
Historically, Waleed H Hassanein's trades have earned a middling insider score of 55/100 across 44 rated trades. Over a 12-month horizon, 32.6% of those trades were profitable, with an average 12-month return of -12.3%.
The TMDX filings lean toward selling, a net 530,480 shares.
Waleed H Hassanein has 52 Form 4 filings on record from May 2019 to July 2026, all as President & CEO at TransMedics Group (TMDX), 2019–2026.
The 141 reported transactions were 96 open-market sales, 20 option exercises, 10 other transactions and 7 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $3.0M and 35 sales worth about $48.4M.
The largest open-market purchase was 16,875 shares of TMDX at an average $117.46 on August 7, 2025, about $2.0M. Twelve months later TMDX was down 28%.
The largest open-market sale was 68,444 shares of TMDX at an average $116.68 on May 2, 2024, about $8.0M. Twelve months later TMDX was down 28%.
10 of the 19 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 9 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | TMDX Transmedics Group, Inc. | President & CEO | Buy | 8,775 | $114.00 | $1,000,350.00 | +1.8% | +18.0% | - | |
| Aug 7, 2025 | TMDX Transmedics Group, Inc. | President & CEO | Buy | 16,875 | $117.46 | $1,982,120.66 | +3.6% | +7.2% | -27.7% | |
| Oct 15, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 8,625 | $132.71 | $1,144,648.13 | -12.3% | -51.4% | -14.6% | |
| Sep 16, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 8,625 | $153.42 | $1,323,209.86 | -12.3% | -57.5% | -21.2% | |
| Aug 22, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE | 45,000 | $173.24 | $7,795,600.00 | -42.2% | -55.5% | -30.9% | |
| Aug 15, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 8,625 | $169.73 | $1,463,918.96 | -12.3% | -45.4% | -24.9% | |
| Jul 15, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 8,625 | $145.17 | $1,252,050.99 | -12.3% | -7.0% | -19.9% | |
| Jun 14, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 8,625 | $141.85 | $1,223,473.20 | -12.3% | +5.0% | +0.6% | |
| May 15, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 8,625 | $135.32 | $1,167,147.18 | -12.3% | +19.0% | -10.5% | |
| May 6, 2024 | TMDX Transmedics Group, Inc. | President & CEO | Sale+OE10b5-1 | 30,000 | $130.07 | $3,902,100.00 | -32.7% | +11.9% | -29.6% |